Sildenafil Citrate NDC 72603-884

Product information

Brand name (proprietary)

Sildenafil Citrate

Generic name (nonproprietary)

sildenafil citrate

Active ingredients

Sildenafil citrate — 50 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Northstar Rx LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209302

Marketing start

Feb 24, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 72603-884_4bb9baea-3bd6-03c0-e063-6294a90a218aSPL ID 4bb9baea-3bd6-03c0-e063-6294a90a218aSPL set ID 8127ff38-2761-49ec-8ce7-7f971f521cfbRxCUI 312950, 314228, 314229UNII BW9B0ZE037UPC 0372603885026, 0372603883015, 0372603884012

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472603088401 followed by a unit qualifier and the quantity Copy

Package 72603-0884-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.